These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8202231)

  • 1. Recurrent migraine: cost-effective care.
    Rapoport AM
    Neurology; 1994 May; 44(5 Suppl 3):S25-8. PubMed ID: 8202231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of migraine and its treatment.
    Goldberg LD
    Am J Manag Care; 2005 Jun; 11(2 Suppl):S62-7. PubMed ID: 16095269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of sumatriptan in a managed care population.
    Legg RF; Sclar DA; Nemec NL; Tarnai J; Mackowiak JI
    Am J Manag Care; 1997 Jan; 3(1):117-22. PubMed ID: 10169243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of migraine management: a pharmacoeconomic overview.
    Rapoport AM; Adelman JU
    Am J Manag Care; 1998 Apr; 4(4):531-45. PubMed ID: 10179912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in migraine management: implications for managed care organizations.
    Dodick DW; Lipsy RJ
    Manag Care; 2004 May; 13(5):45-51. PubMed ID: 15181689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine preventive medications: a reappraisal.
    Adelman JU; Brod A; Von Seggern RL; Mannix LK; Rapoport AM
    Cephalalgia; 1998 Nov; 18(9):605-11. PubMed ID: 9876883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T; Burke TA; Laínez MJ
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment recommendations for migraine.
    Silberstein SD
    Nat Clin Pract Neurol; 2008 Sep; 4(9):482-9. PubMed ID: 18665146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of migraine: Part II. Preventive therapy.
    Noble SL; Moore KL
    Am Fam Physician; 1997 Dec; 56(9):2279-86. PubMed ID: 9402813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost savings in migraine associated with less chest pain on new triptan therapy.
    Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
    Gori S; Morelli N; Acuto G; Caiola F; Iudice A; Murri L
    Minerva Med; 2006 Dec; 97(6):467-77. PubMed ID: 17213783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.